Ardent Health Partners (NYSE:ARDT) Earns Buy Rating from Analysts at Guggenheim

Guggenheim started coverage on shares of Ardent Health Partners (NYSE:ARDT - Free Report) in a research report report published on Wednesday morning, Marketbeat reports. The brokerage issued a buy rating and a $16.00 price objective on the stock.

Other analysts also recently issued research reports about the stock. Truist Financial cut their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a report on Monday, January 6th. Mizuho reduced their target price on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Morgan Stanley lowered their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, January 21st. Stephens restated an "overweight" rating and issued a $22.00 price objective on shares of Ardent Health Partners in a report on Tuesday, April 1st. Finally, Royal Bank of Canada lowered their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Tuesday, March 4th. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $20.58.

Remove Ads

Ardent Health Partners Stock Performance

Shares of NYSE:ARDT traded up $0.39 during midday trading on Wednesday, hitting $12.17. The company had a trading volume of 134,300 shares, compared to its average volume of 404,873. The business's 50-day simple moving average is $13.86 and its 200-day simple moving average is $15.74. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a twelve month low of $11.60 and a twelve month high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. Analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Trading of Ardent Health Partners

Large investors have recently modified their holdings of the stock. Charles Schwab Investment Management Inc. purchased a new position in Ardent Health Partners in the third quarter valued at $526,000. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners in the 3rd quarter valued at about $42,000. Quadrature Capital Ltd purchased a new position in shares of Ardent Health Partners in the 3rd quarter valued at about $229,000. State Street Corp acquired a new position in shares of Ardent Health Partners during the third quarter worth about $1,977,000. Finally, Wellington Management Group LLP purchased a new stake in shares of Ardent Health Partners during the third quarter worth approximately $28,724,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.